Julia Brown has held a variety of executive positions over her 40-year career in the pharmaceutical industry, including as Executive Vice President and Advisor to the CEO of Amylin Pharmaceuticals, Inc. and Executive Vice President of Dura Pharmaceuticals, Inc. Previously, she spent over 25 years with Eli Lilly and Company in progressively senior roles, including Vice President of IVAC Corporation and General Manager of its Vital Signs Division and Vice President of Worldwide Marketing for Hybritech. Julia is an experienced director, having served previously on the boards of directors of eight drug development companies and as chairperson of the Corporate Directors Forum. She is chair emerita of the UC San Diego Foundation and a member of the board of two industry associations. Julia earned her undergraduate degree from Louisiana Tech University and a Master’s degree from Harvard.